Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2013 2
2014 3
2015 1
2016 2
2017 2
2018 1
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Anti-spike antibody response to the COVID vaccine in lymphoma patients.
Della Pia A, Kim GYG, Ip A, Ahn J, Liu Y, Kats S, Koropsak M, Lukasik B, Contractor A, Amin K, Ayyagari L, Zhao C, Gupta A, Batistick M, Leslie LA, Goy AH, Feldman TA. Della Pia A, et al. Among authors: zhao c. PLoS One. 2022 Dec 1;17(12):e0266584. doi: 10.1371/journal.pone.0266584. eCollection 2022. PLoS One. 2022. PMID: 36454941 Free PMC article.
Phase I/II trial of pimasertib plus gemcitabine in patients with metastatic pancreatic cancer.
Van Cutsem E, Hidalgo M, Canon JL, Macarulla T, Bazin I, Poddubskaya E, Manojlovic N, Radenkovic D, Verslype C, Raymond E, Cubillo A, Schueler A, Zhao C, Hammel P. Van Cutsem E, et al. Among authors: zhao c. Int J Cancer. 2018 Oct 15;143(8):2053-2064. doi: 10.1002/ijc.31603. Epub 2018 Aug 9. Int J Cancer. 2018. PMID: 29756206 Free article. Clinical Trial.
The interaction of CRM1 and the nuclear pore protein Tpr.
Zhao CL, Mahboobi SH, Moussavi-Baygi R, Mofrad MR. Zhao CL, et al. PLoS One. 2014 Apr 10;9(4):e93709. doi: 10.1371/journal.pone.0093709. eCollection 2014. PLoS One. 2014. PMID: 24722547 Free PMC article.
An open-label, single-arm, phase 2 trial of the Polo-like kinase inhibitor volasertib (BI 6727) in patients with locally advanced or metastatic urothelial cancer.
Stadler WM, Vaughn DJ, Sonpavde G, Vogelzang NJ, Tagawa ST, Petrylak DP, Rosen P, Lin CC, Mahoney J, Modi S, Lee P, Ernstoff MS, Su WC, Spira A, Pilz K, Vinisko R, Schloss C, Fritsch H, Zhao C, Carducci MA. Stadler WM, et al. Among authors: zhao c. Cancer. 2014 Apr 1;120(7):976-82. doi: 10.1002/cncr.28519. Epub 2013 Dec 11. Cancer. 2014. PMID: 24339028 Free PMC article. Clinical Trial.
12 results